|
US2327890A
(en)
*
|
1940-04-17 |
1943-08-24 |
Parke Davis & Co |
Substituted phenoxyalkyl ethers
|
|
US2745875A
(en)
*
|
1953-06-30 |
1956-05-15 |
Hoechst Ag |
Preparation of nu-acylamino-phenylpropane diols
|
|
US3452040A
(en)
*
|
1966-01-05 |
1969-06-24 |
American Home Prod |
5,5-disubstituted hydantoins
|
|
US3529019A
(en)
*
|
1968-04-23 |
1970-09-15 |
Colgate Palmolive Co |
Alkylaryloxy alanines
|
|
US3849574A
(en)
*
|
1971-05-24 |
1974-11-19 |
Colgate Palmolive Co |
Alpha-substituted-beta-arylthioalkyl amino-acids,for increasing heart rate
|
|
US4315031A
(en)
*
|
1977-09-01 |
1982-02-09 |
Science Union Et Cie |
Thiosubstituted amino acids
|
|
GB1601310A
(en)
*
|
1978-05-23 |
1981-10-28 |
Lilly Industries Ltd |
Aryl hydantoins
|
|
JPS6172762A
(ja)
|
1984-09-17 |
1986-04-14 |
Kanegafuchi Chem Ind Co Ltd |
光学活性ヒダントイン類の製造法
|
|
JPS61212292A
(ja)
*
|
1985-03-19 |
1986-09-20 |
Mitsui Toatsu Chem Inc |
Ｄ−α−アミノ酸の製造方法
|
|
CA1325222C
(en)
|
1985-08-23 |
1993-12-14 |
Lederle (Japan), Ltd. |
Process for producing 4-biphenylylacetic acid
|
|
GB8618559D0
(en)
|
1986-07-30 |
1986-09-10 |
Genetics Int Inc |
Rhodococcus bacterium
|
|
US4983771A
(en)
*
|
1989-09-18 |
1991-01-08 |
Hexcel Corporation |
Method for resolution of D,L-alpha-phenethylamine with D(-)mandelic acid
|
|
NL9000386A
(nl)
|
1990-02-16 |
1991-09-16 |
Stamicarbon |
Werkwijze voor de bereiding van optisch aktief aminozuuramide.
|
|
DK161690D0
(da)
|
1990-07-05 |
1990-07-05 |
Novo Nordisk As |
Fremgangsmaade til fremstilling af enantiomere forbindelser
|
|
IL99957A0
(en)
|
1990-11-13 |
1992-08-18 |
Merck & Co Inc |
Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them
|
|
PH31245A
(en)
*
|
1991-10-30 |
1998-06-18 |
Janssen Pharmaceutica Nv |
1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
|
|
US5308853A
(en)
*
|
1991-12-20 |
1994-05-03 |
Warner-Lambert Company |
Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
|
|
US5246943A
(en)
*
|
1992-05-19 |
1993-09-21 |
Warner-Lambert Company |
Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
|
|
NL9201230A
(nl)
|
1992-07-09 |
1994-02-01 |
Dsm Nv |
Werkwijze voor de bereiding van optisch aktief methionineamide.
|
|
EP0640594A1
(en)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Hydantoin derivative as metalloprotease inhibitor
|
|
WO1995014025A1
(en)
|
1993-11-16 |
1995-05-26 |
Merck & Co., Inc. |
Piperidinylcamphorsulfonyl oxytocin antagonists
|
|
DE69534213T2
(de)
|
1994-10-25 |
2006-01-12 |
Astrazeneca Ab |
Therapeutisch wirksame Heterocyclen
|
|
ZA96211B
(en)
|
1995-01-12 |
1996-07-26 |
Teva Pharma |
Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
US6166041A
(en)
*
|
1995-10-11 |
2000-12-26 |
Euro-Celtique, S.A. |
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
|
|
AU711907B2
(en)
*
|
1995-11-22 |
1999-10-21 |
Darwin Discovery Limited |
Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (MMP) and/or tumor necrosis factor (TNF)
|
|
GB9616643D0
(en)
*
|
1996-08-08 |
1996-09-25 |
Chiroscience Ltd |
Compounds
|
|
US5919790A
(en)
*
|
1996-10-11 |
1999-07-06 |
Warner-Lambert Company |
Hydroxamate inhibitors of interleukin-1β converting enzyme
|
|
ES2171905T3
(es)
*
|
1996-10-22 |
2002-09-16 |
Upjohn Co |
Acidos alfa-amino sulfonilo hidroxamicos como inhibidores de metaloproteinasa de matriz.
|
|
WO1998050359A1
(en)
|
1997-05-06 |
1998-11-12 |
Novo Nordisk A/S |
Novel heterocyclic compounds
|
|
PT877019E
(pt)
*
|
1997-05-09 |
2002-05-31 |
Hoechst Ag |
Acidos diaminocarboxilicos substituidos
|
|
IL133369A
(en)
|
1997-07-31 |
2004-12-15 |
Abbott Lab |
Inverted hydroxamate compounds and their matrix-inhibiting matrix-metalloproteinase preparations
|
|
TW514634B
(en)
|
1997-10-14 |
2002-12-21 |
Lilly Co Eli |
Process to make chiral compounds
|
|
NZ504387A
(en)
|
1997-11-12 |
2002-10-25 |
Darwin Discovery Ltd |
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
|
|
KR20010040698A
(ko)
*
|
1998-02-04 |
2001-05-15 |
한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 |
기질 분해 메탈로프로테이나제를 억제하는 술포닐아미노유도체
|
|
US6329418B1
(en)
*
|
1998-04-14 |
2001-12-11 |
The Procter & Gamble Company |
Substituted pyrrolidine hydroxamate metalloprotease inhibitors
|
|
JP2002514644A
(ja)
|
1998-05-14 |
2002-05-21 |
デュポン ファーマシューティカルズ カンパニー |
メタロプロテイナーゼ阻害剤としての置換アリールヒドロキサム酸
|
|
KR20010052503A
(ko)
*
|
1998-06-03 |
2001-06-25 |
다니엘 피. 맥컬럼 |
Ｎ-헤테로사이클릭 카복실산 또는 카복실산 등입체의ｎ-결합된 설폰아미드
|
|
AU4692399A
(en)
*
|
1998-06-17 |
2000-01-05 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
FR2782082B3
(fr)
*
|
1998-08-05 |
2000-09-22 |
Sanofi Sa |
Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
|
|
US6339101B1
(en)
*
|
1998-08-14 |
2002-01-15 |
Gpi Nil Holdings, Inc. |
N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
|
|
JP2002526370A
(ja)
|
1998-10-07 |
2002-08-20 |
矢崎総業株式会社 |
多孔質型を用いたゾル・ゲル法
|
|
DE69915004T2
(de)
*
|
1998-11-05 |
2004-09-09 |
Pfizer Products Inc., Groton |
5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
|
|
US6340691B1
(en)
*
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
JP3715202B2
(ja)
|
1999-01-28 |
2005-11-09 |
中外製薬株式会社 |
置換フェネチルアミン誘導体
|
|
US20020006920A1
(en)
*
|
1999-07-22 |
2002-01-17 |
Robinson Ralph Pelton |
Arylsulfonylamino hydroxamic acid derivatives
|
|
EP1078923B1
(en)
*
|
1999-08-02 |
2006-03-08 |
F. Hoffmann-La Roche Ag |
Process for the preparation of benzothiophene derivatives
|
|
EP1202733B1
(en)
*
|
1999-08-12 |
2005-10-05 |
Pharmacia Italia S.p.A. |
3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
|
US6283379B1
(en)
*
|
2000-02-14 |
2001-09-04 |
Kic Thermal Profiling |
Method for correlating processor and part temperatures using an air temperature sensor for a conveyorized thermal processor
|
|
SK287071B6
(sk)
*
|
2000-02-21 |
2009-11-05 |
Astrazeneca Ab |
Deriváty N-hydroxyformamidov substituované piperidínom a piperazínom, farmaceutická kompozícia, ktorá ich obsahuje, spôsob ich prípravy a ich použitie
|
|
US6525202B2
(en)
*
|
2000-07-17 |
2003-02-25 |
Wyeth |
Cyclic amine phenyl beta-3 adrenergic receptor agonists
|
|
US20020065219A1
(en)
*
|
2000-08-15 |
2002-05-30 |
Naidu B. Narasimhulu |
Water soluble thiazolyl peptide derivatives
|
|
US20020091107A1
(en)
*
|
2000-09-08 |
2002-07-11 |
Madar David J. |
Oxazolidinone antibacterial agents
|
|
EP1191024A1
(en)
|
2000-09-22 |
2002-03-27 |
Harald Tschesche |
Thiadiazines and their use as inhibitors of metalloproteinases
|
|
SE0100902D0
(sv)
*
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
CN1509275A
(zh)
*
|
2001-03-15 |
2004-06-30 |
|
金属蛋白酶抑制剂
|
|
SE0100903D0
(sv)
*
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
ATE445400T1
(de)
*
|
2001-05-25 |
2009-10-15 |
Bristol Myers Squibb Co |
Hydantion-derivate als hemmer von matrix- metalloproteinasen
|
|
GB0114004D0
(en)
*
|
2001-06-08 |
2001-08-01 |
Glaxo Group Ltd |
Chemical compounds
|
|
SE0103710D0
(sv)
*
|
2001-11-07 |
2001-11-07 |
Astrazeneca Ab |
Compounds
|
|
JP4485941B2
(ja)
|
2002-06-05 |
2010-06-23 |
株式会社カネカ |
光学活性α−メチルシステイン誘導体の製造方法
|
|
SE0202539D0
(sv)
*
|
2002-08-27 |
2002-08-27 |
Astrazeneca Ab |
Compounds
|
|
GB0221250D0
(en)
|
2002-09-13 |
2002-10-23 |
Astrazeneca Ab |
Compounds
|
|
GB0221246D0
(en)
*
|
2002-09-13 |
2002-10-23 |
Astrazeneca Ab |
Compounds
|
|
US20040266832A1
(en)
*
|
2003-06-26 |
2004-12-30 |
Li Zheng J. |
Crystal forms of 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl pyridine
|
|
TWI220073B
(en)
*
|
2003-07-24 |
2004-08-01 |
Au Optronics Corp |
Method for manufacturing polysilicon film
|
|
SE0401762D0
(sv)
|
2004-07-05 |
2004-07-05 |
Astrazeneca Ab |
Novel compounds
|
|
SE0401763D0
(sv)
*
|
2004-07-05 |
2004-07-05 |
Astrazeneca Ab |
Compounds
|
|
US7648992B2
(en)
*
|
2004-07-05 |
2010-01-19 |
Astrazeneca Ab |
Hydantoin derivatives for the treatment of obstructive airway diseases
|
|
SE0403086D0
(sv)
*
|
2004-12-17 |
2004-12-17 |
Astrazeneca Ab |
Compounds
|
|
SE0403085D0
(sv)
|
2004-12-17 |
2004-12-17 |
Astrazeneca Ab |
Novel componds
|
|
TW200800954A
(en)
|
2006-03-16 |
2008-01-01 |
Astrazeneca Ab |
Novel crystal modifications
|
|
TW200740769A
(en)
*
|
2006-03-16 |
2007-11-01 |
Astrazeneca Ab |
Novel process
|
|
TW200831488A
(en)
*
|
2006-11-29 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|